MedPage Today on MSN
First TAVR System Approved for Severe Aortic Regurgitation
Limited launch expected for JenaValve's Trilogy System ...
The FDA has approved the Trilogy Transcatheter Heart Valve System for treating patients with symptomatic severe aortic ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...
JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...
Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option ...
Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...
With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...
I'm a 79-year-old female.
Breast arterial calcification on screening mammograms is an independent predictor of major adverse cardiovascular events and mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results